Elbauomy Elsheikh S, Green AR, Lambros MB, et al. FGFR1 amplification in breast carcinomas: a chromogenic in situ hybridisation analysis[J]. Breast Cancer Res,2007, 9(2):R23.
[2]
Pond AC, Herschkowitz JI, Schwertfeger KL, et al. Fibroblast growth factor receptor signaling dramatically accelerates tumorigenesis and enhances oncoprotein translation in the mouse mammary tumor virus-Wnt-1 mouse model of breast cancer[J]. Cancer Res,2010, 70(12):4868-4879.
[3]
Turner N, Pearson A, Sharpe R, et al. FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer[J]. Cancer Res,2010, 70(5):2085-2094.
[4]
Massabeau C, Sigal-Zafrani B, Belin L, et al. The fibroblast growth factor receptor 1 (FGFR1), a marker of response to chemoradiotherapy in breast cancer [J].Breast Cancer Res Treat,2012, 134(1):259-266.
[5]
Reis-Filho JS, Simpson PT, Turner NC, et al. FGFR1 emerges as a potential therapeutic target for lobular breast carcinomas[J]. Clin Cancer Res,2006,12(22):6652-6662.
M Tenhagen , P J van Diest , I A Ivanova,et al. Fibroblast growth factor receptors in breast cancer: expression, downstream effects, and possible drug targets[J]. Endocrine Relate Cancer,2012,19(4):R115-129.
[8]
Brunello E, Brunelli M, Bogina G,et al.FGFR-1 amplification in metastatic lymph-nodal and haematogenous lobular breast carcinoma[J].J Exp Clin Cancer Res,2012,31(1):103.
